Publications

Preclinical
World ADC San Diego
October 16, 2023
ZW251 – A novel glypican-3 targeting ADC bearing a topoisomerase I inhibitor payload
Laurence Madera
Preclinical
AACR-EORTC-NCI
October 12, 2023
Refining our understanding of ADCs: Drug development insights from 40 years of data
Raffaele Colombo
Preclinical
Festival of Biologics
October 10, 2023
TOPO1i ADC Platform From Concept to Pipeline Application
Mark Petersen
Preclinical
World Bispecific Summit
October 2, 2023
Engineering Trispecific T-cell Engagers to Address Biological Challenges in the Treatment of Solid Tumors
Nina Weisser
Preclinical
Journal of Medicinal Chemistry
June 12, 2023
Structure–Activity Relationships of Bis-Intercalating Peptides and Their Application as Antibody–Drug Conjugate Payloads
Petersen et al.
Preclinical
Bioorganic & Medicinal Chemistry Letters
June 2, 2023
Generation and structure-activity relationships of novel imidazo-thienopyridine based TLR7 agonists: application as payloads for immunostimulatory antibody drug-conjugates
Brant et al.
Preclinical
PEGS
May 15 - May 19, 2023
Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)
Garnett et al.
Preclinical
PEGS
May 15 - May 19, 2023
TriTCE Co-Stim, Next Generation Co-Stimulatory Trispecific T cell Engagers for the Treatment of Solid Tumors
Bhojane et al.